REF: 2017-698
Subject: Eczema patients
Request:
How many patients are currently being treated for moderate or severe atopic dermatitis (also known as eczema)?
Please split these patients by their current drug treatment; Acitretin, Alitretinoin, Pimecrolimus, Tacrolimus, Dupixient (dupilumab), Phototherapy including with ultraviolet (UVB) radiation or psoralen-ultraviolet A (PUVA), Potent Topical Corticosteroids (see list below) Immunosuppressive therapies (see list below).
Potent Topical Corticosteroids [creams or ointments]
- Amcinonide 0.05% (Cyclocort)
- Betamethasone diproprionate 0.05% (Diprosone)
- Betamethasone valerate
- Clobetasol propionate
- Desoximetasone 0.25% (Topicort)
- Diflucortolone valerate
- Fluocinonide 0.05% (Lidex)
- Fluticasone proprionate 0.005% (Cutivate)
- Halcinonide 0.05% (Halog)
- Mometasone furoate 0.1% (Elocon ointment)
- Triamcinalone acetonide 0.5% (Kenalog, Aristocort cream)
- Betamethasone diproprionate 0.25% (Diprolene)
- Clobetasol diproprionate 0.05% (Temovate)
- Diflorasone diacetate 0.05% (Psorcon)
- Halbetasol proprionate 0.05% (Ultravate)
Immunosuppressive therapies
- Azathioprine
- Ciclosporin
- methotrexate
Response:
| We do no record this information.
|